Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.
This post first appeared in The New York Times – Business. Read the original article.The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
The New York Times – Business:
Written by
in
